Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.

Keywords

Biodistribution, Pharmacokinetics, Boron, Melanin, Melanoma

References

• A new mouse tumor model system (rif-1) for comparison of end-point studies.Twentyman, P R, Brown, J M, Gray, J W — 1980
• Treatment of Malignant Melanoma by Selective Thermal Neutron Capture Therapy Using Melanoma-Seeking Compound.Yutaka Mishima, Masamitsu Ichihashi, Masayuki Tsuji — 1989

Cited by

• p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections.Sarah K. Chase, E. Irving, N. Long — 1995
• Which proliferation markers for routine immunohistology? A comparison of five antibodies.Danièle Thomas — 1994
• Argyrophilic nucleolar organizer regions may help the differential diagnostic distinction between chronic pancreatitis and pancreatic ductal adenocarcinoma.Scott D. Johnson — 1994
• The polymerase chain reaction in diagnosing lymphoid disordersMaría Crístina Abarca Parra — 2004
• Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinomaFloyd Hoffman — 2001
• Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphomaErin McCloskey — 2001
• Characterising and Predicting Haploinsufficiency in the Human GenomeJeffry J. Stone — 2010
• Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.Günther Mahal — 2011
• Endonucleases and apoptosis in animalsL. Sánchez Clavería, D. Aradilla Zapata, Ramón Oliver Pujol — 2012
• Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib.Jae-Chul Kim, Majid Ali, Animesh Nandi — 2005
• Apoptotic markers for tumor recurrence: A minireviewA. E. Konstantinidou, Penelope Korkolopoulou, Efstratios Patsouris — 2002
• En hälsoekonomisk modellstudie av primärscreening mot livmoderhalscancer med cellprov- och HPV DNA-testPeter Bistoletti, Karin Sennfält — 2008
• Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma.John C. Reed, Toshiyuki Miyashita, Stanisław Krajewski — 1996
• New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic AcidsOlga Patutina, Н. Л. Миронова, Valentin V. Vlassov — 2009
• Treatment of Nausea and Vomiting During ChemotherapyKaren M. Mustian, Katie A. Devine, Julie L. Ryan — 2011
• Detection and Relevance of Minimal Disease in LymphomasJohn Sharp, Wing C. Chan — 2004
• Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.Armando López‐Guillermo, Fernando Cabanillas, Timothy McDonnell — 1999
• A CLINICOPATHOLOGIC STUDY OF ODONTOGENIC KERATOCYST (OKC) AND THE ROLE OF AgNORs IN CELL PROLIFERATIONVindhya Savithri, S Sudha, Ipe Varghese — 2010
• Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.P. Lipponen, S. Aaltomaa, S Papinaho — 1993
• AgNOR in human Leydig cell tumors.M. Mueller, Heidrun Lauke — 1997

Related papers

• The biodistribution of NC100668 and the effect of excess NC100668 on the biodistribution and kidney retention of (99m)Tc-NC100668 in the rat.David S. Edwards, Joanne Lewis, Mark Battle — 2007
• Melanin enhances metastatic melanoma colonization by inhibiting ferroptosisArwin Groenewoud, Gangyin Zhao, Maria Chiara Gelmi — 2023
• Progresses in research of boron porphyrins for boron neutron capture therapyPu Manfei — 2011
• Motor development in school‐age children is associated with the home environment including socioeconomic statusEmanuela Binello, Sonya Shortkroff, J. C. Yanch — 2018
• Spectromicroscopy of boron for the optimization of boron neutron capture therapy (BNCT) for cancerBenjamin Gilbert, J. Redondo, P. A. Baudat — 1998
• Molecular engineering of AIE-active boron clustoluminogens for enhanced boron neutron capture therapyWenli Ma, Yanyang Wang, Yilin Xue — 2024
• 58 POSTER Application of Boron-Entrapped WOW Emulsion as boron delivery carrier for boron neutron capture therapy on VX-2 rabbit hepatic cancer modelHironobu Yanagië, Shinji Higashi, Ichiro Ikushima — 2006
• Synthesis of Boron-Containing Amino Acid for Boron Neutron Capture Therapy基哲 朴 — 2000